Virax Biolabs Group (VRAX) News Today $1.75 -0.14 (-7.41%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Virax Biolabs Announces Strategic Goals and Developments for 2025December 18, 2024 | markets.businessinsider.comVirax Biolabs' CEO James Foster Issues Letter to ShareholdersDecember 17, 2024 | prnewswire.comVirax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and SwitzerlandDecember 10, 2024 | prnewswire.comVirax Biolabs Sees Asset Growth Amid Financial LossNovember 22, 2024 | markets.businessinsider.comVirax Biolabs announces distribution agreement with Europa BiositeOctober 24, 2024 | markets.businessinsider.comVirax Biolabs Expands Reach with Europa Biosite DealOctober 24, 2024 | markets.businessinsider.comVirax Biolabs Signs Distribution Agreement With Europa Biosite To Sell ImmuneSelect; Stock UpOctober 23, 2024 | markets.businessinsider.comVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and IrelandOctober 23, 2024 | prnewswire.comVirax Biolabs Group Ltd Class A VRAXOctober 6, 2024 | morningstar.comVirax Biolabs Group (NASDAQ:VRAX) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comNovo Nordisk A/S (NOVA.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comVirax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.September 16, 2024 | prnewswire.comVirax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferenceSeptember 9, 2024 | prnewswire.comVirax Biolabs to Participate at 7th European Congress of ImmunologyAugust 29, 2024 | prnewswire.comWhy Virax Biolabs Is Rising In Pre-market?August 29, 2024 | markets.businessinsider.comWhat's Going On With Virax Biolabs Stock WednesdayAugust 29, 2024 | msn.comVirax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastAugust 28, 2024 | prnewswire.comVirax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesAugust 23, 2024 | prnewswire.comVirax Biolabs Announces Stock Offering: What To KnowAugust 22, 2024 | msn.comVirax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesAugust 21, 2024 | prnewswire.comVirax Biolabs Group (NASDAQ:VRAX) Stock Quotes, Forecast and News SummaryAugust 20, 2024 | benzinga.comVirax Biolabs Shares Climb With Mpox Cases: What To KnowAugust 19, 2024 | msn.comVRAX Virax Biolabs Group LimitedJuly 21, 2024 | seekingalpha.comWhy Is Virax Biolabs (VRAX) Stock Down 15% Today?June 7, 2024 | investorplace.comWhy Is Virax Biolabs (VRAX) Stock Up 115% Today?June 6, 2024 | investorplace.comVirax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024April 25, 2024 | prnewswire.comVirax Biolabs to Participate at ESCMID Global 2024April 16, 2024 | finance.yahoo.comVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyMarch 15, 2024 | prnewswire.comVirax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsDecember 21, 2023 | finance.yahoo.comTrading was temporarily halted for "VRAX" at 07:12 PM with a stated reason of "News pending."December 18, 2023 | marketbeat.comVirax Biolabs announces 1-for-10 share consolidationDecember 14, 2023 | msn.comVirax Biolabs Group Limited Announces 1-for-10 Share ConsolidationDecember 14, 2023 | finance.yahoo.comVirax Biolabs files for up to $30M mixed securities shelfDecember 7, 2023 | msn.comVirax Biolabs Group Ltd OrdOctober 2, 2023 | thestreet.comVRAX: Virax Biolabs transformative preventive diagnostic platform supports higher stock price.September 21, 2023 | finance.yahoo.comVirax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarSeptember 12, 2023 | finance.yahoo.comVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumSeptember 1, 2023 | finance.yahoo.comNasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidAugust 3, 2023 | finance.yahoo.comVRAX: Virax Biolabs releases shareholder letter and financial results for the fiscal year ending March 31, 2023.June 21, 2023 | finance.yahoo.comVRAX: UPDATE: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology.May 5, 2023 | finance.yahoo.comVirax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science ParkMay 4, 2023 | finance.yahoo.comVirax Biolabs Group Limited Ordinary Shares (VRAX)April 21, 2023 | nasdaq.comVirax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesMarch 10, 2023 | finance.yahoo.comVirax Biolabs Group Stock (NASDAQ:VRAX), DividendsMarch 8, 2023 | benzinga.comVirax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesMarch 8, 2023 | finance.yahoo.comVirax Biolabs Stock Soars On Avian Flu Test Kit Agreement: What's Going On?March 7, 2023 | msn.comEXCLUSIVE: Virax Biolabs Starts Distribution Of Avian Flu Test Kits In EuropeMarch 7, 2023 | finance.yahoo.comWhy Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionMarch 7, 2023 | benzinga.comVirax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test KitMarch 7, 2023 | prnewswire.comVRAX: INITIATION: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technologyFebruary 16, 2023 | finance.yahoo.com Get Virax Biolabs Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… VRAX Media Mentions By Week VRAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRAX News Sentiment▼0.000.60▲Average Medical News Sentiment VRAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRAX Articles This Week▼20▲VRAX Articles Average Week Get Virax Biolabs Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tenax Therapeutics News Today Citius Pharmaceuticals News Today Finch Therapeutics Group News Today Cognition Therapeutics News Today Cadrenal Therapeutics News Today MIRA Pharmaceuticals News Today Unity Biotechnology News Today Carisma Therapeutics News Today Pieris Pharmaceuticals News Today Aprea Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRAX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
